A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

NCT03357263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: GC3114
BIOLOGICAL: GCFLU Quadrivalent

Sponsor

Green Cross Corporation